What’s the biggest health threat astronauts face beyond Earth’s orbit? It’s not zero gravity or isolation. It’s radiation. And understanding how to measure and manage it is key to the future of space health research. On…
More than 55 million people worldwide live with dementia, and Alzheimer’s disease accounts for over 60–70% of those cases. Alzheimer’s is a progressive neurodegenerative disorder that affects memory, thinking, and behavior. Early symptoms—like forgetfulness or confusion—often…
The Ax-4 mission — Axiom Space’s fourth commercial astronaut flight to the International Space Station launched on June 25th and we’re thrilled to announce that TrialX is once again playing a key role in advancing space health…
In the world of clinical research, the distance between a study’s design and the real lives it’s meant to impact can feel vast. Trial protocols are written, materials are approved, and recruitment goals are set, but…
Making clinical trials more diverse isn’t just the right thing to do — it’s essential for developing treatments that work for everyone. Yet, despite FDA guidance, many trials still fail to reflect the real-world diversity of…
Over the past five years, the rapid commercialization of spaceflight, led by companies like SpaceX, Axiom Space, and Blue Origin, has transformed who can go to space. This shift has introduced a new category of explorers:…
Collecting accurate, consistent data is one of the toughest parts of running a clinical trial. It gets even harder when patients are spread across locations or reporting frequently. That’s why more research teams are turning to…
